EASI Access II --- Follow-up Study to the EASI Access Trial
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Test whether Basic Life Support (BLS) providers can successfully place Enzymatically
Augmented Subcutaneous Infusion (EASI) Access lines for subcutaneous infusion, and
characterize intravascular absorption of EASI-administered (tracer-labelled) glucose (D5W).